Braxia Scientific CEO Dr Roger McIntyre joined Steve Darling from Proactive to share news the company has agreed to a non-binding amended and restated letter of intent for a business combination with Irwin Naturals Inc. (CSE:IWIN) McIntyre telling Proactive this transaction will assembles an experienced management and scientific team in mental health treatment, research and development. The combined company will have 17 specialized mental health clinics across North America, enhanced telehealth platform and access to critical treatments for millions of people across multiple states in the U.S.
Braxia Scientific signs non-binding letter of intent to sell company to Irwin Naturals
